Free Trial

TransCode Therapeutics (RNAZ) Insider Trading & Ownership

TransCode Therapeutics logo
$0.52
+0.04 (+8.42%)
(As of 11/4/2024 ET)

TransCode Therapeutics (NASDAQ:RNAZ) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.16%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$167,403.20
Number Of
Insiders Selling
(Last 3 Years)
0
Get RNAZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling TransCode Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RNAZ Insider Buying and Selling by Quarter

TransCode Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/28/2023Robert Michael DudleyCEOBuy2,450$20.40$49,980.00  
9/28/2023Thomas A FitzgeraldCFOBuy1,233$20.40$25,153.20  
6/20/2023Robert Michael DudleyCEOBuy165$102.00$16,830.00  
6/9/2023Robert Michael DudleyCEOBuy475$110.40$52,440.00  
9/14/2022Robert Michael DudleyCEOBuy25$920.00$23,000.00  
(Data available from 1/1/2013 forward)

RNAZ Insider Trading Activity - Frequently Asked Questions

The list of insiders at TransCode Therapeutics includes Robert Michael Dudley, and Thomas A Fitzgerald. Learn more on insiders at RNAZ.

0.16% of TransCode Therapeutics stock is owned by insiders. Learn more on RNAZ's insider holdings.

The following insiders have purchased RNAZ shares in the last 24 months: Robert Michael Dudley ($119,250.00), and Thomas A Fitzgerald ($25,153.20).

Insiders have purchased a total of 4,323 RNAZ shares in the last 24 months for a total of $144,403.20 bought.

TransCode Therapeutics Key Executives

  • Mr. Thomas A. Fitzgerald M.B.A. (Age 72)
    Interim CEO, CFO, President, VP of Administration & Director
    Compensation: $358.14k
  • Dr. Philippe P. Calais Ph.D. (Age 65)
    Pharm., Pharm.D., Executive Chairman of the Board
    Compensation: $102.5k
  • Dr. Zdravka Medarova Ph.D. (Age 49)
    Co-Founder & Chief Scientific Officer
  • Dr. Anna Moore Ph.D. (Age 62)
    Co-Founder, Scientific Advisor & Member of Scientific Advisory Board
  • Ms. Susan Duggan M.B.A.
    R.N., Senior Vice President of Operations
  • Dr. Daniel R. Vlock M.D. (Age 72)
    Chief Medical Officer


This page (NASDAQ:RNAZ) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners